FEVCX
Price
$19.79
Change
-$0.13 (-0.65%)
Updated
Dec 17 closing price
RIDAX
Price
$24.61
Change
-$0.13 (-0.53%)
Updated
Dec 17 closing price
Ad is loading...

FEVCX vs RIDAX

Header iconFEVCX vs RIDAX Comparison
Open Charts FEVCX vs RIDAXBanner chart's image
First Eagle US Value C
Price$19.79
Change-$0.13 (-0.65%)
VolumeN/A
CapitalizationN/A
American Funds Income Fund of Amer R1
Price$24.61
Change-$0.13 (-0.53%)
VolumeN/A
CapitalizationN/A
FEVCX vs RIDAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FEVCX vs. RIDAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEVCX is a Hold and RIDAX is a Buy.

FUNDAMENTALS
Fundamentals
RIDAX has more cash in the bank: 123B vs. FEVCX (1.38B). RIDAX pays higher dividends than FEVCX: RIDAX (2.82) vs FEVCX (0.44). FEVCX was incepted earlier than RIDAX: FEVCX (23 years) vs RIDAX (23 years). RIDAX is a more actively managed with annual turnover of: 40.00 vs. FEVCX (6.62). RIDAX has a lower initial minimum investment than FEVCX: RIDAX (250) vs FEVCX (2500). FEVCX annual gain was more profitable for investors over the last year : 12.58 vs. RIDAX (10.05). FEVCX (17.99) and RIDAX (17.26) have equivalent 5 years return.
FEVCXRIDAXFEVCX / RIDAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD11.3878.721131%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B123B1%
Annual Yield % from dividends0.442.8216%
Returns for 1 year12.5810.05125%
Returns for 3 years5.464.51121%
Returns for 5 years17.9917.26104%
Returns for 10 years-0.4128.11-1%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPK1.610.01
+0.62%
OPKO Health
PFG77.54-1.13
-1.44%
Principal Financial Group
HI30.81-0.69
-2.19%
Hillenbrand
VRA3.88-0.10
-2.51%
Vera Bradley
BTAI0.39-0.02
-4.01%
BioXcel Therapeutics